Boston Scientific Corp. Announces Canadian Approval And Launch Of PROMUS Element Plus Stent System

Boston Scientific Corp. announced Health Canada approval and market launch of the PROMUS Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System in Canada. The first patient implant in Canada using the new device was recently performed by Philippe L'Allier, M.D., Cath Lab Director at the Montreal Heart Institute. The new stent system incorporates the platinum chromium (PtCr) alloy and stent design of the PROMUS Element Stent with an enhanced catheter delivery system engineered for improved performance in treating patients with coronary artery disease. The Company plans to begin marketing the product immediately in Canada. The PROMUS Element Stent, part of the PROMUS Element Stent System and the PROMUS Element Plus Stent System, uses a PtCr alloy designed specifically for coronary stenting, which enables enhanced visibility, less recoil, excellent conformability and higher radial strength.